Verde Clean Fuels, Inc. (VGAS) stock intrinsic value fair value estimate & owner earnings analysis

What the business is. Verde Clean Fuels owns STG+, a process that turns synthesis gas made from natural gas or biomass into finished gasoline that needs no further refining. The technology has run for more than 10,000 hours at a demonstration plant in Hillsborough, New Jersey, and roughly $150 million has gone into it since 2007. The company has never had revenue. Its only commercial project, a gas-to-gasoline plant in the Permian Basin with Diamondback Energy's subsidiary Cottonmouth (its second-largest shareholder), finished its front-end engineering study in December 2025. Verde suspended the project in February 2026 because rising demand for Permian gas removed the cheap, stranded feedstock the plant depended on. It wrote off $3.9 million of project costs. The company then switched to a "capital-lite" plan of licensing the technology and selling engineering services, cut costs, named a new CEO and, in March 2026, hired an adviser to look at a sale, merger, licensing deal or other options. Bluescape Energy Partners controls the company through 22.5 million Class C shares, which can be exchanged one-for-one for Class A shares. We value all 44.55 million economic shares. Earnings history. The business has always consumed cash. Owner cash flow (operating cash flow excluding working-capital swings, with stock compensation and capital spending counted as costs) was about -$4.8 million in 2022, -$11.7 million in 2023, -$13.0 million in 2024 and -$17.9 million in 2025. That is roughly -$0.41 to -$0.45 per share each year from 2023 to 2025. Much of the 2024-2025 capital spending ($2.6 million and $7.7 million) went into the suspended Permian project. With no revenue, we count all of it as a cost. The February 2026 restructuring changed the cost base, so we measure the ongoing burn from 2026's two reported quarters instead of the older years. First-half 2026 capital spending was $0.46 million against $2.0 million a year earlier, and general and administrative expense fell from $6.1 million to $5.0 million, with Q2 alone down to $2.4 million. On the Q2 run rate, the company spends about $10.5 million a year including stock compensation, partly offset by roughly 4% interest on its cash. In 2025 the burn got 37% worse. In year one of our base case it improves by about 40%. We accept that reversal because of the dated February 6 and February 18, 2026 decisions and because two quarters of results already show it. What is worth something. The company has no debt. At June 30, 2026 it held $53.5 million in cash, which is about $1.20 per share. The technology gets no value in any case. There is no signed license, customer, offtake or project, and a working demonstration plant is not a contract. The Permian project could restart, and its engineering study is finished, but nothing says it will, so we credit no growth. The tax receivable agreement with Bluescape could require payments of up to $50 million if the company changes control. Those payments depend on tax benefits from Class C exchanges, and at today's values they look small, so we leave them out. They would matter in a sale at a much higher value. The shares are therefore worth whatever cash is left for shareholders after the company stops spending. Base case ($0.67 per share): The adviser-led process ends in a sale, merger, licensing arrangement or wind-down about two years after June 2026. Spending continues at the Q2 2026 rate until then, and deal, severance and closing costs come to about $3 million. About $33 million is left in mid-2028. Discounted at 6%, it is worth about $29.7 million today. The operating business subtracts about $24 million of present value from the $53.5 million in cash. There is no debt. Bear case ($0.13 per share): This follows the company's actual 19-year record. The controlling holder keeps it looking for a way to deploy STG+ for five more years, spending at today's reduced rate with no revenue. About $8 million of cash is left at the end, worth about $5.7 million today. The business consumes about $48 million of present value against $53.5 million of cash, again with no debt. New equity raised for a project would make this worse through dilution. We do not model that because no such plan is disclosed. Bull case ($0.98 per share): The cost program gets close to its stated 50% cut, bringing total costs to about $7.5 million a year. The strategic process ends within about a year, with about $2 million of transaction costs, and shareholders receive the remaining cash of about $46 million. That is worth about $43.5 million today, or $10 million less than the cash on hand, with no debt. Even this case gives nothing for the technology, because no acquirer or licensee has been named. What would make this wrong. The main upside is a real licensing deal, a restart of the Diamondback project or an acquirer that pays for the technology. Any of these would add value that none of our cases include. The main downside is spending that goes on longer than the bear case assumes, or new share issuance to fund a plant. Price alone does not provide a margin of safety here, because the value depends on how quickly spending stops. The margin-of-safety price assumes the company commits to an outcome that ends open-ended spending. It sits well below the base case because a controlling shareholder decides how long the cash keeps being spent.